Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

Kidney International

Volumn 74, Issue 12, 2008, Pages 1610-1616

  Reich, Heather N ^a   Oudit, Gavin Y ^a   Penninger, Josef M ^b   Scholey, James W ^a   Herzenberg, Andrew M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

ACE2; Diabetes mellitus; Glomerulosclerosis; Immunohistochemistry; Real time RT PCR; Renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ANALYSIS; FEMALE; GLOMERULUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TUBULE; LASER MICRODISSECTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; TISSUE DISTRIBUTION;

EID: 57049086924     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.497     Document Type: Article

References (23)

1. Lewis EJ, Hunsicker LG, Bain RP, et al., for the Collaborative Study Group. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
2. Lewis EJ, Hunsicker LG, Clarke WR, et al., for the Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
3. Brenner BM, Cooper ME, de Zeeuw D, et al., RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
4. Burrell LM, Johnston CI, Tikellis C et al. ACE2, a new regulator of the renin-angiotensin system. Trends Endocrinol Metab 2004; 15: 166-169.
5. Li N, Zimpelmann J, Cheng K et al. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 2005; 2: 353-362.
6. Warner FJ, Lew RA, Smit AI et al. Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem 2005; 280: 39353-39361.
7. Ye M, Wysocki J, William J et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17: 3067-3075.
8. Lely AT, Hamming I, van Goor H et al. Renal ACE2 expression in human kidney disease. J Pathol 2004; 204: 587-593.
9. Oudit GY, Herzenberg AM, Kassiri Z et al. Loss of angiotensin-converting enzyme 2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 2006; 168: 1808-1820.
10. Soler MJ, Wysocki J, Ye M et al. ACE2 inhibition worsens glomerular injury associated with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 2007; 72: 614-623.
11. Konoshita T, Wakahara S, Mizuno S et al. Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 2006; 29: 848-852.
12. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibits angiotensin IIstimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006; 69: 2212-2218.
13. Wong DW, Oudit GY, Reich H et al. Loss of angiotensin converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007; 171: 438-451.
14. Crackower MA, Sarao R, Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002; 417: 822-828.
15. Zimpelmann J, Kumar D, Levine DZ et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int 2000; 58: 2320-2330.
16. Huang W, Gallois Y, Bouby N et al. Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc Natl Acad Sci USA 2001; 98: 13330-13334.
17. Tikellis C, Johnston CI, Forbes JM et al. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41: 392-397.
18. Wysocki J, Ye M, Soler MJ et al. ACE and ACE2 activity in diabetic mice. Diabetes 2006; 55: 2132-2139.
19. Ye M, Wysocki J, Naaz P et al. Increased ACE2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 2004; 43: 1120-1125.
20. Ferrario CM, Jessup J, Gallagher PE et al. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymers and receptors. Kidney Int 2005; 68: 2189-2196.
21. Zimmerman D, Donnelly S, Miller J et al. Gender disparity in living renal transplant donation. Am J Kidney Dis 2000; 36: 534-540.
22. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
23. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.